https://www.statcounter.com/counter/counter.js
Web Analytics
Home » Posts tagged with » diabetes
Aptar wins FDA approval for Unidose Powder System for nasal spray of hypoglycemia drug

Aptar wins FDA approval for Unidose Powder System for nasal spray of hypoglycemia drug

AptarGroup (Aptar) said that its Unidose Powder System has been approved by the US Food and Drug Administration (FDA) for the intranasal, needle-free rescue treatment drug – Lilly’s Baqsimi nasal powder, which was indicated for the treatment of severe hypoglycemia in people with diabetes. (Read Baqsimi FDA approval) The announcement marks the first approval by […]

Lilly secures Baqsimi FDA approval for severe hypoglycemia

Baqsimi FDA approval : Eli Lilly and Company (Lilly) has secured the US Food and Drug Administration (FDA) approval) for Baqsimi nasal powder for the treatment of severe hypoglycemia in patients with diabetes aged four years and older. According to the FDA, Baqsimi is the first glucagon therapy approved for the emergency treatment of the […]

Continue reading …
Baxter secures Myxredlin FDA approval for insulin IV infusion

Myxredlin FDA approval : US health care company Baxter International has secured approval from the US Food and Drug Administration (FDA) for Myxredlin (Insulin Human in 0.9% Sodium Chloride Injection), a ready-to-use insulin for IV infusion. Myxredlin is approved for use as a short-acting human insulin to enhance glycemic control in adults and pediatric patients […]

Continue reading …
Xeris Pharmaceuticals begins dosing in phase 2 trial of ready-to-use glucagon

US pharma company Xeris Pharmaceuticals announced that it has started dosing in a phase 2 trial with its ready-to-use, room temperature stable liquid glucagon in Type 1 diabetes patients who face episodes of exercise-induced hypoglycemia (EIH). Xeris Pharmaceuticals is a specialty pharma company based in Chicago that utilizes its novel technology platforms to develop and […]

Continue reading …
Novo Nordisk bags insulin aspart injection Fiasp FDA approval for diabetes

Fiasp FDA approval : Danish pharmaceutical company Novo Nordisk has secured the US FDA approval for its new fast-acting mealtime insulin aspart injection Fiasp 100 Units/mL for diabetes treatment in adults. Already approved in Canada and Europe, Fiasp is the addition of two excipients to Novo Nordisk’s insulin aspart (NovoLog) in a new formulation with […]

Continue reading …